- Home
- CRBP vs BRAG Comparison
CRBP vs BRAG Comparison
Compare CRBP & BRAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- BRAG
- Stock Information
- Founded
- CRBP 2009
- BRAG 2018
- Country
- CRBP United States
- BRAG Canada
- Employees
- CRBP N/A
- BRAG 502
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- BRAG Office Equipment/Supplies/Services
- Sector
- CRBP Health Care
- BRAG Technology
- Exchange
- CRBP Nasdaq
- BRAG Nasdaq
- Market Cap
- CRBP 96.5M
- BRAG 108.9M
- IPO Year
- CRBP N/A
- BRAG N/A
- Fundamental
- Price
- CRBP $8.22
- BRAG $4.61
- Analyst Decision
- CRBP Strong Buy
- BRAG Strong Buy
- Analyst Count
- CRBP 10
- BRAG 3
- Target Price
- CRBP $53.56
- BRAG $7.33
- AVG Volume (30 Days)
- CRBP 214.0K
- BRAG 51.8K
- Earning Date
- CRBP 08-05-2025
- BRAG 08-07-2025
- Dividend Yield
- CRBP N/A
- BRAG N/A
- EPS Growth
- CRBP N/A
- BRAG N/A
- EPS
- CRBP N/A
- BRAG N/A
- Revenue
- CRBP N/A
- BRAG $112,078,469.00
- Revenue This Year
- CRBP N/A
- BRAG $17.94
- Revenue Next Year
- CRBP $150.03
- BRAG $9.56
- P/E Ratio
- CRBP N/A
- BRAG N/A
- Revenue Growth
- CRBP N/A
- BRAG 9.76
- 52 Week Low
- CRBP $4.64
- BRAG $2.86
- 52 Week High
- CRBP $61.90
- BRAG $6.12
- Technical
- Relative Strength Index (RSI)
- CRBP 54.23
- BRAG 67.98
- Support Level
- CRBP $7.26
- BRAG $4.23
- Resistance Level
- CRBP $7.90
- BRAG $4.50
- Average True Range (ATR)
- CRBP 0.53
- BRAG 0.13
- MACD
- CRBP -0.01
- BRAG 0.04
- Stochastic Oscillator
- CRBP 78.59
- BRAG 74.19
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.